DOI QR코드

DOI QR Code

Graft Patency of No-Touch Saphenous Veins Used as Aortocoronary Bypass Grafts

  • Jeongwon Kim (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Suk Ho Sohn (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Jae-Sung Choi (Department of Thoracic and Cardiovascular Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine) ;
  • Se Jin Oh (Department of Thoracic and Cardiovascular Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine) ;
  • Ho Young Hwang (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2023.02.22
  • Accepted : 2023.07.02
  • Published : 2023.09.05

Abstract

Background: This study evaluated the early, 1-year, and 3-year graft patency rates and mid-term clinical outcomes after no-touch saphenous veins (NT-SVs) were used as aortocoronary grafts in coronary artery bypass grafting (CABG). Methods: In total, 101 patients who underwent CABG using NT-SVs as aortocoronary grafts were included. The 2 most common indications for performing aortocoronary grafting with NT-SVs were unavailability of the left internal thoracic artery (n=36) and moderate lesions where flow competition was expected (n=27). Early (median, 1 day; interquartile range [IQR], 1-2 days), 1-year (median, 13 months; IQR, 11-16 months), and 3-year (median, 34 months; IQR, 27-41 months) graft angiography was performed in 98 (97.0%), 84 (83.2%), and 40 patients (39.6%), respectively. The median follow-up duration was 43 months (IQR, 13-76 months). Overall survival rates and the cumulative incidence of major adverse cardiac events were evaluated. Results: The operative mortality rate was 2% (2 of 101 patients). Early postoperative patency rates for overall and aortocoronary NT-SV grafts were 98.2% (223 of 227 distal anastomoses) and 98.2% (164 of 167), respectively. The 1- and 3-year patency rates for aortocoronary SV grafts were 94.9% (131 of 138) and 90.6% (58 of 64), respectively. The overall survival rates at 5 and 10 years were 81.7% and 59%, respectively. The cumulative incidence of major adverse cardiac events at 5 and 10 postoperative years was 20.7% and 39%, respectively. Conclusion: The feasibility of using NT-SVs as aortocoronary grafts in CABG was shown in this study, based on the graft patency rates up to 3 years and the mid-term clinical outcomes.

Keywords

References

  1. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6. https://doi.org/10.1056/NEJM198601023140101
  2. Hwang HY, Oh HC, Kim YH, Kim KB. Complete revascularization of the three-vessel territories using a left internal thoracic artery composite graft. Ann Thorac Surg 2015;100:59-66. https://doi.org/10.1016/j.athoracsur.2015.01.068
  3. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts: effects on survival over a 15-year period. N Engl J Med 1996;334:216-9. https://doi.org/10.1056/NEJM199601253340402
  4. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011;58:e123-210. https://doi.org/10.1016/j.jacc.2011.08.009
  5. Kulik A, Le May M, Wells GA, Mesana TG, Ruel M. The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]. Curr Control Trials Cardiovasc Med 2005;6:15. https://doi.org/10.1186/1468-6708-6-15
  6. Souza DS, Christofferson RH, Bomfim V, Filbey D. "No-touch" technique using saphenous vein harvested with its surrounding tissue for coronary artery bypass grafting maintains an intact endothelium. Scand Cardiovasc J 1999;33:323-9. https://doi.org/10.1080/14017439950141362
  7. Hwang HY, Kim JS, Cho KR, Kim KB. Bilateral internal thoracic artery in situ versus y-composite graftings: five-year angiographic patency and long-term clinical outcomes. Ann Thorac Surg 2011;92:579-86. https://doi.org/10.1016/j.athoracsur.2011.03.145
  8. Hwang HY, Lee Y, Sohn SH, Choi JW, Kim KB. Equivalent 10-year angiographic and long-term clinical outcomes with saphenous vein composite grafts and arterial composite grafts. J Thorac Cardiovasc Surg 2021;162:1535-43. https://doi.org/10.1016/j.jtcvs.2020.01.109
  9. Hwang HY, Kim KB. Saphenous vein as a composite graft from the internal thoracic artery. Ann Cardiothorac Surg 2018;7:686-9. https://doi.org/10.21037/acs.2018.06.08
  10. Souza DS, Johansson B, Bojo L, et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. J Thorac Cardiovasc Surg 2006;132:373-8. https://doi.org/10.1016/j.jtcvs.2006.04.002
  11. Johansson BL, Souza DS, Bodin L, et al. Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. Eur J Cardiothorac Surg 2010;38:414-9. https://doi.org/10.1016/j.ejcts.2010.02.007
  12. Kim YH, Oh HC, Choi JW, Hwang HY, Kim KB. No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results. Ann Thorac Surg 2017;103:1489-97. https://doi.org/10.1016/j.athoracsur.2016.09.024
  13. Chin AK, Mayer DN, Goldman RK, Lerman JA, Olcott C 4th, Fogarty TJ. The effect of valvulotomy on the flow rate through the saphenous vein graft: clinical implications. J Vasc Surg 1988;8:316-20. https://doi.org/10.1067/mva.1988.avs0080316
  14. Thubrikar MJ, Robicsek F, Fowler BL. Pressure trap created by vein valve closure and its role in graft stenosis. J Thorac Cardiovasc Surg 1994;107:707-16. https://doi.org/10.1016/s0022-5223(94)70326-4
  15. Villareal RP, Mathur VS. The string phenomenon: an important cause of internal mammary artery graft failure. Tex Heart Inst J 2000;27:346-9.
  16. Lim HA, Kang JK, Kim HW, Song H, Lim JY. The neutro-phil-to-lymphocyte ratio as a predictor of postoperative outcomes in patients undergoing coronary artery bypass grafting. J Chest Surg 2023;56:99-107. https://doi.org/10.5090/jcs.22.082
  17. Kim HH, Kim JH, Lee S, et al. Long-term outcomes of preoperative atrial fibrillation in cardiac surgery. J Chest Surg 2022;55:378-87. https://doi.org/10.5090/jcs.21.146
  18. Yoon SK, Song H, Lim JY. Effect of the proximal anastomosis configuration of the radial artery in patients undergoing coronary artery bypass grafting. J Chest Surg 2021;54:117-26. https://doi.org/10.5090/jcs.20.082
  19. Kim KB, Lim C, Lee C, et al. Off-pump coronary artery bypass may decrease the patency of saphenous vein grafts. Ann Thorac Surg 2001;72:S1033-7. https://doi.org/10.1016/s0003-4975(01)02946-0
  20. Campeau L, Enjalbert M, Lesperance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 1983;68(3 Pt 2):II1-7.
  21. Deb S, Cohen EA, Singh SK, et al. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol 2012;60:28-35. https://doi.org/10.1016/j.jacc.2012.03.037
  22. Tranbaugh RF, Dimitrova KR, Friedmann P, et al. Coronary artery bypass grafting using the radial artery: clinical outcomes, patency, and need for reintervention. Circulation 2012;126(11 Suppl 1):S170-5. https://doi.org/10.1161/CIRCULATIONAHA.111.083048
  23. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991;34:45-68. https://doi.org/10.1016/0033-0620(91)90019-i
  24. Souza DS, Dashwood MR, Tsui JC, et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg 2002;73:1189-95. https://doi.org/10.1016/s0003-4975(02)03425-2
  25. Gusic RJ, Myung R, Petko M, Gaynor JW, Gooch KJ. Shear stress and pressure modulate saphenous vein remodeling ex vivo. J Biomech 2005;38:1760-9. https://doi.org/10.1016/j.jbiomech.2004.10.030
  26. Kim JS, Kim AH, Jang C, et al. Comparison of the plasma metabolome profiles between the internal thoracic artery and ascending aorta in patients undergoing coronary artery bypass graft surgery using gas chromatography time-of-flight mass spectrometry. J Korean Med Sci 2019;34:e104. https://doi.org/10.3346/jkms.2019.34.e104
  27. Kang Y, Kim JS, Cui H, Jang MJ, Zhang YH, Hwang HY. Comparative analysis of the hydrogen sulphide pathway in internal thoracic artery and radial artery. Interact Cardiovasc Thorac Surg 2022;35:ivac105. https://doi.org/10.1093/icvts/ivac105
  28. Gaudino M, Audisio K, Di Franco A, et al. Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery bypass grafting. Eur J Cardiothorac Surg 2022;62:ezac345. https://doi.org/10.1093/ejcts/ezac345
  29. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2022;145:e18-114. https://doi.org/10.1161/CIR.0000000000001038
  30. Yun T, Kim JS, Kang Y, Sohn SH, Hwang HY. Use of the in situ right internal thoracic artery as an alternative single-inflow source. Ann Thorac Surg Short Rep 2023 Apr 14 [Epub]. https://doi.org/10.1016/j.atssr.2023.04.001